SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism

Citations Over TimeTop 1% of 2010 papers

Abstract

SMARTCyp is an in silico method that predicts the sites of cytochrome P450-mediated metabolism of druglike molecules. The method is foremost a reactivity model, and as such, it shows a preference for predicting sites that are metabolized by the cytochrome P450 3A4 isoform. SMARTCyp predicts the site of metabolism directly from the 2D structure of a molecule, without requiring calculation of electronic properties or generation of 3D structures. This is a major advantage, because it makes SMARTCyp very fast. Other advantages are that experimental data are not a prerequisite to create the model, and it can easily be integrated with other methods to create models for other cytochrome P450 isoforms. Benchmarking tests on a database of 394 3A4 substrates show that SMARTCyp successfully identifies at least one metabolic site in the top two ranked positions 76% of the time. SMARTCyp is available for download at http://www.farma.ku.dk/p450.

Related Papers

• → Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes(2021)94 cited
• → Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity(2012)15 cited
• → Deletion of 30 Murine Cytochrome P450 Genes Results In Viable Mice With Compromised Drug Metabolism(2014)21 cited
• → Roles of Human Cytochrome P450 Enzymes Involved in Drug Metabolism and Toxicological Studies(2000)7 cited
• → ChemInform Abstract: Roles of Human Cytochrome P450 Enzymes Involved in Drug Metabolism and Toxicological Studies(2001)